Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases. The company accelerates the development of new treatments through differentiated research platforms and a multitude of treatment modalities, including for conditions like idiopathic pulmonary fibrosis and cancer.
Parse Score
#167 of 169 in Fractional C-Suite Consulting Services
Sources
reuters.com shapes more of what AI says about Bristol-Myers Squibb than any other source, at 100% of its citations.
The market map
Fractional C-Suite Consulting Services →Where AI ranks Bristol-Myers Squibb